By designating one reference listed drug because the common to which all generic versions must be revealed being bioequivalent, FDA hopes to stay away from possible substantial versions among the generic drugs as well as their manufacturer name counterpart. Quoted prices are for dollars-spending shoppers and so are not valid with insurance cover